Holen Sie sich die Stockscreener-App
5.65
0.53%
0.03
Handel nachbörslich:
5.64
-0.01
-0.18%
Schlusskurs vom Vortag:
$5.62
Offen:
$5.61
24-Stunden-Volumen:
13.94M
Relative Volume:
1.29
Marktkapitalisierung:
$8.20B
Einnahmen:
$17.58B
Nettoeinkommen (Verlust:
$449.34M
KGV:
0.6907
EPS:
8.18
Netto-Cashflow:
$1.17B
1W Leistung:
+0.89%
1M Leistung:
+4.05%
6M Leistung:
-11.58%
1J Leistung:
-27.84%
1-Tages-Spanne:
$5.53
$5.75
1-Wochen-Bereich:
$5.495
$5.75
52-Wochen-Spanne:
$5.00
$9.265
Cemex S A B De C V Adr Stock (CX) Company Profile
Firmenname
Cemex S A B De C V Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie CX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CX
Cemex S A B De C V Adr
|
5.65 | 8.20B | 17.58B | 449.34M | 1.17B | 0.2974 |
|
CRH
Crh Plc
|
93.64 | 63.48B | 35.39B | 3.49B | 2.41B | 5.00 |
|
VMC
Vulcan Materials Co
|
263.13 | 34.75B | 7.40B | 845.70M | 803.80M | 6.34 |
|
MLM
Martin Marietta Materials Inc
|
533.69 | 32.62B | 6.51B | 1.98B | 520.10M | 32.09 |
|
JHX
James Hardie Industries Plc Adr
|
31.68 | 13.61B | 3.94B | 439.40M | 377.50M | 1.01 |
|
SUM
Summit Materials Inc
|
50.50 | 8.87B | 3.75B | 147.37M | 169.46M | 0.82 |
Cemex S A B De C V Adr Stock (CX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-11 | Herabstufung | RBC Capital Mkts | Sector Perform → Underperform |
| 2024-10-29 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-10-08 | Hochstufung | RBC Capital Mkts | Underperform → Sector Perform |
| 2024-08-21 | Fortgesetzt | JP Morgan | Overweight |
| 2024-07-31 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-07-10 | Fortgesetzt | Goldman | Buy |
| 2024-05-14 | Eingeleitet | RBC Capital Mkts | Underperform |
| 2024-04-24 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-02-09 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-09 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-11-02 | Fortgesetzt | Citigroup | Buy |
| 2023-05-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-05-05 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-05-04 | Hochstufung | Goldman | Neutral → Buy |
| 2022-12-08 | Eingeleitet | Redburn | Neutral |
| 2022-09-20 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2022-06-10 | Herabstufung | Berenberg | Buy → Hold |
| 2022-04-20 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-04-05 | Herabstufung | Goldman | Buy → Neutral |
| 2022-02-23 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2021-10-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-06-15 | Fortgesetzt | Berenberg | Buy |
| 2021-04-23 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2021-01-28 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-01-20 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-09-29 | Eingeleitet | UBS | Buy |
| 2020-09-15 | Hochstufung | Goldman | Neutral → Buy |
| 2020-09-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-09-01 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2020-07-15 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-04-17 | Herabstufung | Loop Capital | Hold → Sell |
| 2020-04-06 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2020-04-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-12-19 | Eingeleitet | Loop Capital | Hold |
| 2019-04-29 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-04-11 | Eingeleitet | Goldman | Neutral |
| 2018-08-16 | Herabstufung | HSBC Securities | Buy → Hold |
| 2018-07-31 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2018-04-27 | Herabstufung | Longbow | Buy → Neutral |
| 2017-12-19 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-10-23 | Hochstufung | Citigroup | Sell → Neutral |
| 2017-07-17 | Herabstufung | Citigroup | Neutral → Sell |
| 2017-06-20 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-04-04 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2017-03-31 | Hochstufung | Longbow | Neutral → Buy |
Alle ansehen
Cemex S A B De C V Adr Aktie (CX) Neueste Nachrichten
(CX) Investment Analysis and Advice - Stock Traders Daily
AES Corp (NYSE: AES) Down -29.77% This Year: What To Expect Next - Stocks Register
Form N-CSRS World Funds Trust For: Sep 30 - StreetInsider.com
Cemex S.A.B. De C.V. ADR (CX) Volatility Hits 3.87%: What Good Investors Need To Be Aware Of - Stocks Register
(CX) Technical Data - Stock Traders Daily
Data-Based Insights About Cemex S.A.B. De C.V. ADR (CX) - Stocks Register
New Outlook On Ibotta Inc - Stocks Register
Cemex's SWOT analysis: stock outlook amid global shifts and strategic moves - Investing.com
(CX) Proactive Strategies - Stock Traders Daily
Mexico stocks lower at close of trade; S&P/BMV IPC down 1.25% - MSN
Mexico shares lower at close of trade; S&P/BMV IPC down 1.25% - Investing.com India
Earnings call: CEMEX reports robust growth amid divestitures and weather challenges By Investing.com - Investing.com South Africa
Earnings call: CEMEX reports robust growth amid divestitures and weather challenges - Investing.com Canada
Mexico stocks higher at close of trade; S&P/BMV IPC up 0.06% - Investing.com
Mexico shares higher at close of trade; S&P/BMV IPC up 0.06% - Investing.com India
Cemex Q3 earnings miss estimates, stock down 8% - Investing.com India
Cemex stock touches 52-week low at $5.49 amid market challenges - Investing.com
Cemex's SWOT analysis: global cement giant faces margin pressure, stock outlook mixed - Investing.com
Vista Oil & Gas, S.A.B. de C.V. Sponsored ADR (VIST) Q3 Earnings Lag Estimates - Yahoo Finance
(CX) Investment Analysis - Stock Traders Daily
Volatility Of Cemex S.A.B. De C.V. ADR (CX) Reaches 2.01%: Make Sure To Keep Your Seat Tight! - Stocks Register
A Guide To The Risks Of Investing In Cemex S.A.B. De C.V. ADR (CX) - Knox Daily
Checking in on Microvision Inc. (MVIS) after recent insiders movement - Knox Daily
Driving Growth in the Construction Aggregates Market: Innovations and Trends Shaping the Future - Future Market Insights
The growth track for Cemex S.A.B. De C.V. ADR (CX) has changed recently - SETE News
Can Cemex S.A.B. De C.V. ADR Bounce Back? 52-Week Performance and Analyst Predictions - The InvestChronicle
CEMEX, S.A.B. de C.V. (CX): Leader in Best Cement and Construction Materials Stock - Yahoo Finance
Insider’s View: Deciphering Cemex S.A.B. De C.V. ADR (CX)’s Financial Health Through Ratios - The Dwinnex
Analysts review Cemex S.A.B. De C.V. ADR’s rating - Knox Daily
A stock that deserves closer examination: Cemex S.A.B. De C.V. ADR (CX) - US Post News
Barclays upgrades Evolus Inc (EOLS) stock to an Overweight - Knox Daily
Cemex S.A.B. De C.V. ADR [CX] Stock trading around $5.88 per share: What’s Next? - The DBT News
Analyst Forecast For Clearside Biomedical Inc (NASDAQ: CLSD) - Stocks Register
Cemex S.A.B. De C.V. ADR’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle
Where Do Analysts See AgriFORCE Growing Systems ltd (NASDAQ: AGRI) Heading? - Stocks Register
Are Smart Investors Making the Right Decision? Cemex S.A.B. De C.V. ADR (CX) - SETE News
Mexico stocks higher at close of trade; S&P/BMV IPC up 1.81% - Investing.com
What Are the Chances of Cemex S.A.B. De C.V. ADR (CX) Stagnating? Here is the INSIGHT - US Post News
Cemex S.A.B. De C.V. ADR (CX) may enjoy gains as insiders got busy in the recent days - Knox Daily
A better buy-in window may exist right now for Cemex S.A.B. De C.V. ADR (CX) - SETE News
Market Momentum: Cemex S.A.B. De C.V. ADR (CX) Registers a -1.93 Decrease, Closing at 6.10 - The Dwinnex
For Cemex S.A.B. De C.V. ADR [CX], Analyst sees a rise to $8. What next? - The DBT News
Trading (CX) With Integrated Risk Controls - Stock Traders Daily
Teva- Pharmaceutical Industries Ltd. ADR (TEVA): Worth A Small Bite At $17.54 - Stocks Register
Wall Street SWOT: Cemex stock balances debt reduction with growth potential - Investing.com
Adversity is less terrifying than hope: Cemex S.A.B. De C.V. ADR (CX) - SETE News
Construction Aggregates Market is Set to Fly High in Years to Come - Newstrail
Cemex S.A.B. De C.V. ADR (NYSE: CX) – Analysts’ Revisions Point To Positive Sentiment - Stocks Register
In the Green: Cemex S.A.B. De C.V. ADR (CX) Closes at 6.36, Up/Down 2.91 from Previous Day - The Dwinnex
Freshworks Inc (NASDAQ: FRSH) Metrics That Matter Right Now - Stocks Register
Does Cemex S.A.B. De C.V. ADR (CX) offer a good opportunity for investors? - SETE News
Finanzdaten der Cemex S A B De C V Adr-Aktie (CX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.76%
0.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):